A report indicates that inflation could be a significant concern in FY26 due to rising raw material costs, geopolitical tensions, and currency depreciation.
Hospitalisation claims for cancer rise 12% in 2024, followed by cardiac issues. Respiratory ailments also see significant inflation in treatment costs.